Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nanni Hua"'
Publikováno v:
Journal of International Medical Research, Vol 52 (2024)
Objective Most patients with colorectal cancer (CRC) show no early symptoms, and tumor markers have low sensitivity and specificity. We therefore investigated the ability of serum fibrin degradation complex DR-70 plus traditional tumor markers to dia
Externí odkaz:
https://doaj.org/article/b41366dc0e904663a19731a8e602b755
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 139, Iss , Pp 111573- (2021)
The incidence of hematological malignancies such as multiple myeloma, leukemia, and lymphoma has increased over time. Although bone marrow transplantation, immunotherapy and chemotherapy have led to significant improvements in efficacy, poor prognosi
Externí odkaz:
https://doaj.org/article/dd492ff29cc6479b9a79b6ae16dd3646
Autor:
Min Fei, Yi Wu, Lei Wang, Chen Yang, Shufang Xie, Xiangmin Tong, Nanni Hua, Lifen Zhu, Shibing Wang, Wanmao Ni
Publikováno v:
Cancer Management and Research
Despite efforts to abrogate the severe threat to life posed by the profound malignancy of mature natural killer/T-cell lymphoma (NKTCL), therapeutic advances still require further investigation of its inherent regulatory biochemical processes. Next-g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96d9d52b577c2d5873e6fcb4aabaa670
https://doi.org/10.2147/cmar.s299505
https://doi.org/10.2147/cmar.s299505
Autor:
Shida, Chen, Mingqi, Zhou, Jing, Yang, Yong-Ran, Cheng, Yanchun, Li, Kang, Lu, Wanye, Hu, Nanni, Hua, Ying, Wang, Xiangmin, Tong
Publikováno v:
Clinical Laboratory. 68
The goal of this study is to explore the clinical value of routine tests in multiple myeloma (MM).A total of 179 MM patients, newly diagnosed in our hospital from January 2010 to December 2018 (case group), as well as 352 cases of healthy individuals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa340603659a8951f6ef2193b806ca2
https://doi.org/10.7754/clin.lab.2021.210716
https://doi.org/10.7754/clin.lab.2021.210716
Autor:
Nanni Hua, Anxian Chen, Chen Yang, Hui Dong, Xianglei He, Guoqing Ru, Xiangmin Tong, Feifei Zhou, Shibing Wang
Background Fibrinogen-like-protein 1 (FGL1), a member of the fibrinogen-related protein (FREP) family, is a major ligand of the immune inhibitory receptor lymphocyte-activation gene 3 (LAG-3). While FGL1 is strongly implicated in the development and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f604d331dd5c407860b713a8ab91fe1
https://doi.org/10.21203/rs.3.rs-1037866/v2
https://doi.org/10.21203/rs.3.rs-1037866/v2
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 139, Iss, Pp 111573-(2021)
The incidence of hematological malignancies such as multiple myeloma, leukemia, and lymphoma has increased over time. Although bone marrow transplantation, immunotherapy and chemotherapy have led to significant improvements in efficacy, poor prognosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15caca291e14aa7982c9addce567d716
http://www.sciencedirect.com/science/article/pii/S0753332221003589
http://www.sciencedirect.com/science/article/pii/S0753332221003589